KO2 Stock Overview
Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Clariane SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.65 |
| 52 Week High | €7.91 |
| 52 Week Low | €1.38 |
| Beta | 0.99 |
| 1 Month Change | 15.18% |
| 3 Month Change | -24.47% |
| 1 Year Change | -76.18% |
| 3 Year Change | -94.89% |
| 5 Year Change | -95.38% |
| Change since IPO | -95.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| KO2 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 3.8% | 5.4% | 1.7% |
| 1Y | -76.2% | 0.6% | 2.3% |
Return vs Industry: KO2 underperformed the German Healthcare industry which returned 1.9% over the past year.
Return vs Market: KO2 underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| KO2 volatility | |
|---|---|
| KO2 Average Weekly Movement | 13.7% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: KO2's share price has been volatile over the past 3 months.
Volatility Over Time: KO2's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Sophie Boissard | www.clariane.com |
Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Clariane SE Fundamentals Summary
| KO2 fundamental statistics | |
|---|---|
| Market cap | €172.99m |
| Earnings (TTM) | -€49.50m |
| Revenue (TTM) | €5.05b |
0.0x
P/S Ratio-3.5x
P/E RatioIs KO2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KO2 income statement (TTM) | |
|---|---|
| Revenue | €5.05b |
| Cost of Revenue | €3.02b |
| Gross Profit | €2.02b |
| Other Expenses | €2.07b |
| Earnings | -€49.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.46 |
| Gross Margin | 40.11% |
| Net Profit Margin | -0.98% |
| Debt/Equity Ratio | 113.4% |
How did KO2 perform over the long term?
See historical performance and comparison